Selecta Biosciences Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
3,040.00
6,011.00
8,083.00
207.00
903
SG&A Expense
17,575.00
30,271.00
41,951.00
63,241.00
64,950
EBIT
15,399.00
25,304.00
34,670.00
63,784.00
65,022
Unusual Expense
-
-
-
673.00
-
Non Operating Income/Expense
2,960.00
907.00
521.00
275.00
130
Interest Expense
552.00
948.00
1,253.00
1,206.00
1,494
Pretax Income
12,880.00
25,174.00
36,210.00
65,321.00
65,336
Consolidated Net Income
12,880.00
25,174.00
36,210.00
65,321.00
65,336
Net Income
12,880.00
25,174.00
36,210.00
65,321.00
65,336
Net Income After Extraordinaries
14,339.00
25,174.00
36,210.00
65,321.00
65,336
Net Income Available to Common
17,831.00
32,509.00
40,776.00
65,321.00
65,336
EPS (Basic)
0.88
1.74
3.89
3.20
2.92
Basic Shares Outstanding
18,649.60
18,649.60
10,493.90
20,425.10
22,389.30
EPS (Diluted)
0.88
1.74
3.89
3.20
2.92
Diluted Shares Outstanding
18,649.60
18,649.60
10,493.90
20,425.10
22,389.30
EBITDA
14,535.00
24,260.00
33,868.00
63,034.00
64,047
Non-Operating Interest Income
111.00
171.00
234.00
617.00
1,050
Preferred Dividends
4,951.00
7,335.00
4,566.00
-
-
About Selecta Biosciences
View Profile
